Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference70 articles.
1. Lefrak, E. A., Pitha, J., Rosenheim, S., & Gottlieb J. A. (1973). A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer, 32(2), 302–314.
2. Gewirtz, D. A. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochemical Pharmacology, 57(7), 727–741.
3. Ferrans, V. J., Clark, J. R., Zhang, J., Yu, Z. X., & Herman, E. H. (1997). Pathogenesis and prevention of doxorubicin cardiomyopathy. Tsitologiia, 39(10), 928–937.
4. Olson, R. D., & Mushlin, P. S. (1990). Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses [see comments]. FASEB Journal, 4(13), 3076–3086.
5. Singal, P. K., & Iliskovic N. (1998). Doxorubicin-induced cardiomyopathy [see comments]. New England Journal of Medicine, 339(13), 900–905.
Cited by
181 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献